This article has been updated to include a comment from City of Hope.
NEW YORK (GenomeWeb News) – Researchers at the City of Hope research and treatment center in Duarte, Calif., will use Helicos BioSciences’ single-molecule sequencing technology to evaluate known cancer-associated gene variants and potentially discover new mutations within those genes, Helicos said today.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.